Association between CD24 Ala/Val polymorphism and multiple sclerosis risk: A meta analysis.

Wan Yang, Wang Zhou, Bo-Kang Zhang, Ling-Suo Kong, Xing-Xing Zhu, Rui-Xiang Wang, Yue Yang, Yun-Fei Chen, Lan-Ren Chen

Journal: Medicine 2020;99(15):e19530

PMID: 32282702

Abstract

BACKGROUND

The aim of this study was to explore the association between CD24 Ala/Val polymorphism and susceptibility of multiple sclerosis (MS).

METHODS

A comprehensive literature search for relevant studies was performed on google scholar, PubMed, Web of science, Embase, the Chinese National Knowledge Infrastructure and the Chinese Biology Medicine. This meta-analysis was conducted using the STATA 11.0 software and the pooled odds ratio with 95% confidence interval was calculated.

RESULTS

Seven case-control studies were included in this meta-analysis. The results showed significant association between CD24 Ala/Val polymorphism and susceptibility to MS. Stratified analysis by areas also showed significant association in Asians. However, no association was found in Europeans.

CONCLUSION

This study suggested that the CD24 Val allele was associated with an increased risk of MS and larger-scale studies of populations are needed to explore the role of CD24 Ala/Val polymorphism during the pathogenesis of MS.

Address: Department of Anesthesiology, Anhui Provincial Cancer Hospital, Hefei.; Department of Anesthesiology, West District of Anhui Provincial Hospital, Hefei.; Department of Anesthesiology, West District of The First Affiliated Hospital of USTC, Division of life Sciences and Medicine, University of Science and Technology of China, Hefei.; Department of Ultrasound, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, PR China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.